Register to Vote: Rock the Vote, powered by Credo Mobile

HOME

ABOUT US

OUR ISSUES

Federal Budget

Information & Access

Nonprofit Advocacy


PRESS ROOM

ACTION CENTER

PUBLICATIONS

THE WATCHER

OUR BLOGS


SIGN UP

Receive news, updates, and alerts!

DONATE

Help support our work


OTHER SITES

FedSpending.org

RTK NET

NPAction

Working Group on Community Right-to-Know

Citizens for Sensible Safeguards

Open the Government

OMB Watch Logo

"[P]eople acting in a group can accomplish things which no individual acting alone could even hope to bring about." - FDR

Case in Point:  

Subtopics

Case in Point

Agency Priorities & Agenda

Rollbacks & Weak Standards

Ineffective Enforcement

Information Gaps

Archive

Bankrupting Government





News
Cow Sense: The Bush Administration's Broken Record on Mad Cow Disease

MadCow The Bush administration has failed the public time and time again on mad cow disease, putting corporate special interests above the public interest.


Read More

Nanotech, Genetically Modified Crop News Spotlights Regulatory Gaps
New evidence of long-term persistence of genetically modified crops and new concerns about gaps in monitoring of nanotechnology underscore the risks from failing to embed the Precautionary Principle in regulatory policy. Read More

Katrina Exposes Some, But Not All, Unmet Security and Safety Needs
While the country may now be cognizant of water contamination and other serious safety gaps prevalent in the regions hit by Hurricane Katrina, health and safety threats are not unique to the Gulf Coast. Read More

Report of Newest U.S. Mad Cow Case Highlights USDA Failures
After seven months of silence, the U.S. Department of Agriculture (USDA) confirmed the second U.S. case of mad cow disease on June 24, highlighting the need for more stringent regulatory protections of the nation's beef supply. Read More

Congress Grapples With Industry Influence at FDA
Efforts to free the Food and Drug Administration from the pharmaceutical industry's excessive influence seesawed between success and failure in the same week, as the House voted to ban drug company scientists from FDA advisory committees while an agency whistleblower revealed that a new drug safety board has been tilted in favor of the drug companies. Read More

House Hearing Reveals Unethical Marketing of Vioxx
During a congressional hearing on May 5, the House Government Reform Committee harshly criticized both the Food and Drug Administration and drug makers for their role in approving and marketing Vioxx, an arthritis painkiller linked to heart disease. Read More

Studies on Health Risks from Pollutants Verify Need for Safeguards
Several recently published scientific studies on the negative health impacts of depleted uranium, diesel engines, mercury and urban pollutants underscore the need for stronger environmental regulations to protect public health. Read More

FDA Announces Drug Safety Oversight Board
The Food and Drug Administration (FDA) plans to initiate an independent oversight board to handle drug safety issues, but some lawmakers and consumer groups say the new panel lacks teeth. Read More

OSHA Must Improve Safety for Meat and Poultry Workers
Recent reports highlight the dangerous and sometimes deadly working conditions faced by workers in the meat industry and the urgent need for the Occupational Safety and Health Administration (OSHA) to take increased actions. Read More

EPA Assessment Finds Potential Risk to Humans in Teflon
While an Environmental Protection Agency draft risk assessment for a chemical compound used in the production of Teflon did find that exposure could lead to adverse health effects, EPA fell far short of condemning the chemical or its makers. Read More


  | < 1 >  2  3  4  Next >>